Adam, Zdeněk <br/><br/>
[Osteoprotective therapy with bisphosphonates or denosumab in patients with multiple myeloma: benefit and risks].  [electronic resource] 

 -  Vnitrni lekarstvi   
 - 311-321 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0042-773X 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Density Conservation Agents--adverse effects<br/>Denosumab--adverse effects<br/>Diphosphonates--adverse effects<br/>Fractures, Bone--chemically induced<br/>Humans<br/>Multiple Myeloma--drug therapy<br/>Osteonecrosis--chemically induced<br/>Quality of Life<br/>Risk